Bioavailability enhancement of coenzyme q10: An extensive review of patents

Recent Patents on Drug Delivery and Formulation

Volumn 4, Issue 3, 2010, Pages 245-255

  Beg, Sarwar ^a   Javed, Shamama ^a   Kohli, Kanchan ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bioavailability; Coenzyme q10; Liposomes; Solid dispersions; Water solubility

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; BIOSOLV; COQ10; COQH CF; COQSOL; DRUG CARRIER; GAMMA CYCLODEXTRIN; HYDROQSORB; INNO Q NOL; KANEKA QH; LABRASOL; LIPOSOME; METAL NANOPARTICLE; MICROSPHERE; NANOPARTICLE; NOVEL COQ10; OMEGA 3 FATTY ACID; PENETRATION ENHANCING AGENT; PHOSPHOLIPID; PLACEBO; PLATINUM NANOPARTICLE; PRODRUG; Q10 CAPSULE; QUINOGEL; REFLEX COENZYME Q10; SURFACTANT; UBIDECARENONE; UBQH; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CHEMICAL MODIFICATION; CYCLIZATION; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; LIPOPHILICITY; LIPOSOMAL DELIVERY; MICROEMULSION; MICRONIZATION; MILLING; MITOCHONDRION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PARTICLE SIZE REDUCTION; PATENT; PRIORITY JOURNAL; PROCESS TECHNOLOGY; REDUCTIVE CYCLIZATION; SELF NANOEMULSIFYING DRUG DELIVERY; SOFT GEL CAPSULE; SOLID DISPERSION;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR WEIGHT; PATENTS AS TOPIC; SOLUBILITY; UBIQUINONE; VITAMINS;

EID: 78649983485     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221110793237565     Document Type: Article

References (82)

1. Healthy, Natural Supplements for Body & Mind. Nutri-herb. Available at: http://www.nutriherb.net/co-q-10.html (Accessed on: Jan 22, 2010).
2. Crane F, Hatefi Y, Lester R, Widmer C. Isolation of a quinine from beef heart mitochondria. Biochim Biophys Acta 1957; 25(1):220-221.
3. Wolf DE, Hoffman CH, Trenner NR, Arison BH, Shunk CH, Linn BO, et al. Coenzyme Q. I. Structure studies on the Coenzyme Q group. J Am Chem Soc 1958; 80(17): 4752.
4. Nakao, Y., Kitano, K., Imada, I., Morimoto, H. Method for producing ubiquinone-10. US4070244 (1978).
5. Amselem, S. Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability. US5989583 (1999).
6. Ubiquinol Enhanced CoQ10: The other half of the coq10 story. Available at: http://www.articlenode.com/articledetail.php?artid=55175&catid=364&title=Ubiquinol+Enhanced+CoQ10:+The+Other+Half+Of+The+Coq10+Story (Accessed on: April 23, 2010).
7. CoQ10 biosynthesis. Available at: http://www.uniprot.org/keywords/831 (Accessed on: March 20, 2010).
8. Parkhideh, D. Methods and compositions that enhance bioavailability of coenzyme-Q10. US7438903 (2008).
9. Zmitek J, Zmitek K, Pravst I. Improving the bioavailability of coenzyme Q10: From theory to practice. Agro Food Ind Hi Tech 2008; 19(4): 8-10.
10. Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 2007; 7: S78-88.
11. Heuer, M., Chaudhuri, S., Clement, K. Compositions and methods for the induction and maintenance of quality sleep. WO2007095716 (2007).
12. Greenwood, A.K., Mchattie, D., Bhatarah, P., Hembra, G. Particle-size reduction apparatus and use thereof. US20060144973 (2006).
13. Greenwood, A.K., Mchattie, D., Bhatarah, P., Hembra, G. Particle-size reduction apparatus and use thereof. US7600703 (2009).
14. Greenwood, A.K., Mchattie, D., Bhatarah, P., Hembra, G. Particle-size reduction apparatus and use thereof. US7644880 (2010).
15. Krayz, G.T., Averbuch, M., Zelkind, I., Gitis, L. Compositions comprising lipophilic active compounds and method for their preparation. US20090098200 (2009).
16. Clement, K., Chaudhuri, S., Heuer, M.A., Peters, J. Fast dissolution amino acid composition-oral dosage formulations for the rapid release of amino acids. US20090203789 (2009).
17. Chaudhuri, S., Heuer, M.A., Gardiner, P.T., Clement, K. Method for promoting sleep - supplemental compositions and methods for administering same to a user are provided for promoting a restful night's sleep. US20090011015 (2009).
18. Minemura, T., Kubota, H., Takagi, S., Nishizawa, Y. Composition comprising ubiquinone. US7026361 (2006).
19. Hovid, B. A self-emulsifying composition for poorly bioavailable drugs. WO2008002121 (2008).
20. Ueda, T., Ono, T., Moro, M., Kitamura, S., Ueda, Y. Method of stabilizing reduced coenzyme Q10. US2005008630 (2005).
21. Chopra, R.K. Reduced form of Coenzyme Q in high bioavailability stable oral dosage form. US6740338 (2004).
22. Olsen, S., Doney, J., Alfred, S., Christophen, S. Bezoquinones of enhanced bioavailability. WO2007014392 (2007).
23. Schroder, B. O/w emulsifier and o/w emulsions containing potassium cetyl phosphate and method for the production thereof. US20060171913 (2006).
24. Westesen, K., Siekmann, B. Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof. US5785976 (1998).
25. Amselem, S. Solid coprecipitates for enhanced bioavailability of lipophilic substances. US5891469 (1999).
26. Nazzal S, Guven N, Reddy IK, Khan MA. Preparation and Drug Dev Ind Pharm 2002; 28(1): 49-57.
27. Olsen, S., Doney, J.A., Shores, C.S. Bezoquinones of enhanced bioavailability. US20070026072 (2007).
28. Rosenberg, J., Breitenbach, J. Stable dosage forms containing ubiquinones. US7273624 (2007).
29. Nepala PR, Hana HK, Choi HK. Enhancement of solubility and dissolution of Coenzyme Q10 using solid dispersion formulation. Int J Pharm 2010; 383(1-2): 147-153.
30. Borowy-borowski, H., Sikorska-walker, M., Walker, R.P. Water-soluble compositions of bioactive lipophilic compounds. US6045826 (2000).
31. Ohashi, H., Takami, T., Koyama, N., Kogure, Y., Ida, K. Aqueous solution containing ubidecarenone. US4483873 (1984).
32. Chokshi, D. CoQ10 composition and methods related thereto. US6806069 (2004).
33. Anders, M.W., Robotham, J.L., Sheu, S.S. Mitochondria-targeted antioxidant prodrugs and methods of use. US20090306125 (2009).
34. Gregor W, Grabner G, Adelwohrer C, Rosenau T, Gille L. Antioxidant properties of natural and synthetic chromanol derivatives: Study by fast kinetics and electron spin resonance spectroscopy. J Org Chem 2005; 70: 3472-3483.
35. Mukai K, Ikeuchi T, Morimoto C, Ishizu K. ESR studies of coenzyme Q1 chromanoxyl and chromenoxyl radicals. Tetrahedron Lett 1984; 25: 1929-1932.
36. Gille L, Stamberg W, Gregor W, Jäger W, Reznicek G, Netscher T, et al. Ubichromanol: A prodrug to support mitochondrial CoQ10 functions? Biofactors 2008; 32(1-4): 83-90.
37. Morgan, A., Charles, Graves, S.S., Woodhouse, C.S., Sikorska, M., Walker, R., Wilbur, D.S., Borowy-Borowski, H. Water soluble CoQ10 compositions, prodrugs, and methods relating thereto. WO96017626 (1996).
38. Strassburger, K.J. Cyclodextrin inclusion complexes and methods of preparing same. US20090029020 (2009),
39. Zmitek J, Smidovnik A, Fir M, Prosek M, Zmitek K, Walczak J, Pravst I. Relative bioavailability of two forms of a novel water-soluble coenzyme Q10. Ann Nutr Metab 2008; 52(4): 281-287.
40. Madhavi, D.L., Kagan, D.I. Highly bioavailable coenzyme Q-10 cyclodextrin complex. US7030102 (2006).
41. Kuo, K.C. Methyl-beta-Cyclodextrin inclusion compound of coenzyme Q10 and its production. JP59047202 (1984).
42. Terao K, Nakata D, Fukumi H, Schmid G, Arima H, Hirayama F, et al. Enhancement of oral bioavailability of coenzyme Q10 by complexation with gamma cyclodextrin in healthy adults. Nutr Res 2006; 26: 503-8.
43. Prosek M, Butinar J, Lukanc B, Fir MM, Milivojevic L, Krizman M, et al. Bioavailability of water-soluble CoQ10 in beagle dogs. J Pharm Biomed Anal 2008; 47(4-5): 918-922.
44. Iga, K., Hamaguchi, N., Ogawa, Y. Liposome composition and production thereof. US5000959 (1991).
45. McCook, J.P., Persaud, I., Narain, N.R. Topical formulations having enhanced bioavailability. US20080233183 (2008).
46. Parkhideh, D. Methods and compositions that enhance bioavailability of Coenzyme-Q10. US20090054530 (2009).
47. Fiorini R, Ragni L, Ambrosi S, Littarru GP, Gratton E, Hazlett T. Fluorescence studies of the interactions of ubiquinol-10 with liposomes. Photochem Photobiol 2008; 84(1): 209-214.
48. Xi S, Xu S, Zhang X. Optimization in the preparation of Coenzyme Q10 nanoliposomes. J Agric Food Chem 2006; 54(17): 6358-6366.
49. A bio-enhanced liposomal Coenzyme Q10 for enhanced absorption. Available at: http://www.epic4health.com/liqlilicodr3.html (Accessed on: April 23, 2010)
50. Jemiota-Rzemi MGS, Dariusz L, Kazimierz SK. Incorporation of plastoquinone and CoQ10 into liposome membranes studied by HPLC analysis. The effect of side chain length and redox state of quinone. Chem Phys Lipids 2001; 110(1): 85-94.
51. Xia S, Xu S, Zhang X, Zhong F, Wang Z. Nanoliposomes mediate Coenzyme Q10 transport and accumulation across human intestinal Caco-2 cell monolayer. J Agric Food Chem 2009; 57(17): 7989-7996.
52. Taki, K., Takahira, H. Ubidecarenone compositions having enhanced absorption properties. US4325942 (1982).
53. Chopra, R.K. Palatable oral coenzyme Q liquid. US6441050 (2000).
54. Kazuo, T., Hideo, T. Ubidecarenone compositions having enhanced absorption properties. US4325942 (1982).
55. Feher, J., Roma, V., Sears, G., Tosarello, V.E. Ubiquinone-con-taining composition suitable for promoting enhanced intramito-chondrial transportation of ubiquinones and methods of using same. EP1123093 (2003).
56. Mora-Gutierrez, A., Gurin, M.H. Bioactive complexes compositions and methods of use thereof. US20070080509 (2007).
57. Ronald, G.U. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing. US6616942 (2003).
58. Ronald, G.U., Siva, P.H. Super absorption coenzyme Q10. US6623734 (2003).
59. Robert, G. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same. US6056971 (2000).
60. Chopra, R.K. Coenzyme Q products exhibiting high dissolution qualities. US6300377 (2001).
61. Pouton CW. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci 2000; 11(2): S93-98.
62. Abdalla A, Klein S, Mader K. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci 2008; 35(5): 457-464.
63. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, et al. Solid self-emulsifying nitrendipine pellets: Preparation and in vitro/in vivo evaluation. Int J Pharm 2010; 383(1-2): 1-6.
64. Chen, F.J., Patel, M.V., Fikstad, D.T., Zhang, H., Gilyar, C. Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs. US20030236236 (2003).
65. Seghizzi, R., Furiosi, G. Oral formulations of ubidecarenone in form of capsules. US5443842 (1995).
66. Udel, R.G. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing. US6616942 (2003).
67. Gupta, P.K., Alvarez, F.J., Semla, S.J. Oil-based tableting method. US5591451 (1997).
68. Okada, M., Hayashi, T., Kasai, S., Iwasa, A. Sustained-release tablet. US5164193 (1992).
69. Desai, M., Molinaro, F. Dry stabilized microemulsified omega-three acid-containing oils. US4867986 (1989).
70. Khan, M.A., Nazzal, S. Eutectic-based self-nanoemulsified drug delivery system. US20030147927 (2003).
71. Franco, P., Antonio, L., Angelo, C. Pharmaceutical composition containing ubidecarenone. US4869900 (1989).
72. Ng, B.H., Choy, W.P., Wong, J.W., Khoo, J.L.C., Ho, D.S.S., Yuen, K.H. A self-emulsifying composition for poorly bioavailable drugs. WO2008002121 (2008).
73. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm 2001; 212(2): 233-246.
74. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, et al. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009; 374(1-2): 66-72.
75. Samad A, Tarique M, Alam MI. In: Fanun M, Ed. Colloids in Drug Delivery. Taylor and Francis Publisher: CRC Press 2010; 455-478.
76. Ozawa Y, Mizushima Y, Koyama I, Akimoto M, Yamagata Y, Hayashi H, et al. Intestinal absorption enhancement of coenzyme Q10 with a lipid microsphere. Arzneimittelforschung 1986; 36(4): 689-690.
77. Josep, G.G. Microcapsules and processes for making the same using various polymers and chitosans. US6733790 (2004).
78. Holbrey, J.D., Spear, S.K., Turner, M.B., Swatloski, R.P., Rogers, R.D. Cellulose matrix encapsulation and method. US6808557 (2004).
79. Ankola DD, Viswanad B, Bhardwaj V, Ramarao P, Kumar MN. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy. Eur J Pharm Biopharm 2007; 67(2): 361-369.
80. Hsu CH, Cui Z, Mumper RJ, Jay M. Preparation and characterization of novel Coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS Pharm Sci Tech 2003; 4(3): article 32.
81. Prestidge, C.A., Simovic, S., Ghouchi E.N. Drug release from nanoparticle-coated capsules. US20090181076 (2009).
82. Hikosaka K, Kim J, Kajita M, Kanayama A, Miyamoto Y. Platinum nanoparticles have an activity similar to mitochondrial NADH:CoQ10oxidoreductase. Coll Surf B: Biointerfaces 2008; 66: 195-200.